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In Vitro Assessment of Equivalence of
Occupational Health Risk: Welders
by R. M. Stern*
The possibility of using in vitro testing to determine the equivalence of risk for various occupa-
tional groups is discussed. In the absence of epidemiological evidence or relevant animal in vivo bio-
assays on which to determine the health effects of specific occupational exposures, it is proposed to
use similarities in the in vitro response to substances with known (or strongly suspected) and un-
known risk to demonstrate their risk equivalence. Identification and evaluation of a high risk "hot
spot" due to exposure to Cr(VI) for stainless steel welders is discussed in terms of recent develop-
ments in collection, analysis and bioassay of welding fumes.
Introduction
Assessment of health risk due to occupation is
difficult in a number of industries where many
workers are exposed to wide and varying ranges of
potentially toxic substances, especially where de-
layed health effects such as emphysema and respi-
ratory tract cancer appear only towards or at the
end of a long working career, frequently after the
critical exposure has ceased. It would be extremely
useful to demonstrate that appropriate in vitro
screening tests could be used in quantitatively as-
sessing health risks associated with some occupa-
tional exposures. In the absence of a methodology
to estimate risk independently, it would be equally
useful to be able to utilize such tests in a semiquan-
titative fashion to rank in order of biological activity
various exposures of alternative technologies. This
would permit a reduction of otherwise unquantified
risk by replacement of suspected processes with
those which were technologically equivalent but
which produce exposures of demonstrably reduced
biological activity. An alternative approach would
be the assessment of equivalent risk whereby expo-
sures in one industry could be demonstrated to pro-
duce an in vitro response identical or similar to
those for comparable substances found in industries
where the associated human risk was known. The
results of preliminary attempts to use such an ap-
proach in the welding industry are described below.
The process of welding, a technology in which 1-
2% of the work force is engaged in the industrial-
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ized countries, produces fume concentrations of the
order of 100-400 mg/m3 in the rising column of
heated air directly above the arc. Average breath-
ing zone concentrations depend to a great extent on
the technology used, but levels of 5 mg/m3 are cur-
rently typical throughout the industry (1, 2).
The extremely wide range of technologies, e.g.,
manual metal arc (MMA) and metal inert gas (MIG),
and their applications to various base materials
such asaluminum(AL), mild steel (MS), and stainless
steel (SS) creates an extraordinary variety of expo-
sures to over 20 different metals, their alloys and
oxides, although a few specific combinations of pro-
cess and materials do provide several well-defined
cohorts with specific process-dependent exposures
which lie within relatively narrow ranges (1,2).
While the presence of high concentrations of cer-
tain toxic substances-e.g., NO2, 03, Cd-in welding
fumes can be related to the risk of acute toxicity in
some exposures, the question of whether or not
welders suffer an average overincidence of various
pneumoconioses (or other delayed health effects) re-
mains unresolved. Wide variations in intergroup in-
cidence, e.g., of small round opacities and of chronic
bronchitis, are found in cross-sectional studies (1),
and the effects of smoking and population dynamics
apparently mask the effect of welding on lung func-
tion (U4). Over 90 cases ofpulmonary fibrosis among
welders have been identified (5), although the inci-
dence rate among welders or of the normal popula-
tion is unknown.
On the other hand, five recent epidemiological
studies of large general welding populations (6-10)
indicate a statistically significant overincidence ofR. M. STERN
respiratory tract cancer (and together show a total
of 417 observed compared to 307 expected cases in
420,000 man years). However, the fact that industry-
wide exposures are so complex makes the determi-
nation of the active carcinogens difficult.
Since exposures within the industry are hetero-
geneous, attention should be focused on the possibil-
ity that there exist "hot spots" of high risk whereby
a relatively small cohort of workers contributes dis-
proportionately to the average risk. This may be
the case for welders of stainless steels, a stable and
identifiable group comprising about 10-15% of the
total welding population, who are exposed to fumes
containing about 5-10% Cr-30-90% of which is in
the form of Cr(VI)-a substance absent in low alloy
steels. A typical stainless steel welding cohort has a
cumulative exposure to Cr(VI) of 5 mg/m3 (years) (1,
11) comparable to that of workers in the chromate
industry (12), where Cr(VI) is a putative carcinogen
(13).
The requirements on cohort size, cumulative ex-
posure and latency-which must be satisfied in
order to generate an epidemiological study of suffi-
cient power to detect a statistically significant over-
incidence of respiratory tract cancer-makes stud-
ies of stainless steel welders prohibitive in most
countries. If it could be demonstrated that occupa-
tional exposures of stainless steel welders and of
chromate industry workers are biologically equiva-
lent and result in equivalent human risk, then,
based on the known risk for the chromate industry,
the entire excess respiratory cancer risk for all
welders could be assigned to this small subcohort
which have been included in the previous studies of
the general welding populations.
A preliminary attempt to demonstrate the hu-
man risk equivalence of stainless steel welding
fumes could be based on comparative studies of the
in vitro and in vivo genotoxicity of welding fumes
and various solubility fractions thereof. The in vivo
transplacental mutagenicity of MMA/SS fumes in
the mouse spot test (Fleckentest) has been shown to
be equivalent to that of the Cr(VI) content, as com-
pared to that from Na2Cr2O7 (14,15). The quantita-
tive response of sister chromatid exchange (SCE)
for mammalian cells in culture to MIG/SS fumes
(16,17) has been shown to be due to the water-solu-
ble Cr(VI) content and is equivalent to that of com-
parable amounts of dichromate; MMA/SS fumes
produce a response which is significantly below that
expected from their Cr(VI) content. Both serum and
water-soluble fractions of Ni, obtained from fume
composed of mixtures of Ni and NiO, induce specific
(molar) SCE rates in human peripheral lymphocytes
comparable with that produced by NiSO, (18). This
Ni; NiO fume shows, in the BHK cell-transformation
test at equitoxic doses, a transformation potency
equal to that of Ni3S2 and Ni(CH3COO)2 (19). This
fume has a tumorigenic potency in rats equal to
that of NiS (20).
In order to further develop the methodology of
risk equivalence studies, it is necessary to examine
some of the details of individual bioassay systems
and to insure that collection, analysis and interpre-
tation of the results are appropriate for the actual
occupational situations for which comparison is in-
tended. The results of some initial efforts in this di-
rection are described below.
Materials and Methods
Production ofWelding Fumes
A welding robot is used to produce a standard
reference welding fume under well-controlled, re-
producible conditions (21,22). Metal inert gas weld-
ing of an 18/8 alloy (Sandvik 3RS17 1.2 mm diam-
eter) wire is performed on matching stainless steel
plates under either spray arc (26 V, 285 A) or short
arc (17 V, 185 A) conditions: shielding gas flow is 15
L/min argon+ 1-2% 02 A ventilation system pro-
vides a flow of 43 L/sec, corresponding to a velocity
of 1.5 m/sec in the 0.3 m diameter, 2.0 m long collec-
tion column, which is fitted with a cowl at its lower
end to insure collection of all fume. An internal disk
insures turbulent mixing.
Collection of Welding Fumes
Fumes are collected either by means of a 0.3 m
diameter paper filter placed at the top of the col-
umn (Whatman #41) (the presence of which reduces
the column flow by a factor of 6 with no fume load-
ing), or by means of a special impinger system, fol-
lowed by a total filter (Millipore 0.2 ,u) shown sche-
matically in Figure 1. For convenience, a single im-
pinger can be used, although its efficiency for weld-
ing fumes is limited to below approximately 60%.
To increase collection efficiency, and to mimic the
human respiratory tract, two impingers can be run
in series: aggregation of the fume in the 100% hu-
midity ofthe first impinger results in a conditioning
which increases the collection efficiency of the sec-
ond impinger compared to the first. A parallel filter
with the same flow is used to monitor the aerosol
passing through the impinger system.
Chemical Analysis ofWelding Fumes
Fumes are routinely analyzed for water-soluble
and -insoluble fractions of Fe, Cr and Cr(VI) (23). It
has been shown that for welding fumes, all water-
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FIGURE 1. Schematic diagram of a two-impinger system for
immediate collection of welding fumes. The collection
medium determines both the efficiency and the stability of
(Cr(VI): doubly deionized, degased water is currently the
collection medium of choice. Collection efficiencies can be
determined by mass balance or by means of comparison
with a parallel filter with similar aerosol flow.
soluble chromium is in the form of Cr(VI), so that
only atomic absorption spectrometry is necessary.
Bioassay of Welding Fumes
The mutagenicity of welding fumes was studied
using S. typhimurium tester strain TA 100 in the
histidine revertant plate incorporation test of Ames
following standard procedures (24) in the absence of
a metabolizing system. In addition, a growing sus-
pension of TA 100 is placed in the (single) impinger
system, in order to study the mutagenicity of fresh
fume. In this assay, aliquots are removed periodical-
ly during collection, half of each to be used for a de-
termination of mutagenicity in minimal agar and
half for a measurement of the corresponding survi-
val rate.
Results and Discussion
The results of a large number of studies of the re-
sponse of TA 100 to various fractions of welding
fumes have recently been analyzed (25). The major
results are schematically presented in Figure 2,
where the number of revertants per plate as a func-
tion of calculated Cr(VI) dose, are shown for MMA/
SS and MIG/SS welding fumes and for Na2Cr2O7. Al-
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FIGURE 2. Schematic dose-response behavior for TA 100 ex-
posed to MMA/SS, MIG/SS welding fumes and Na2Cr207.
The revertants per plate are plotted as a function of Cr(VI)
dose per plate for the various materials.
range of Cr(VI) content (0.02%-0.8%), a linear dose-
response relationship is observed when the number
of revertants is plotted against the actual Cr(VI)
dose per plate. This dose response per mole Cr(VI)
is identical with that found for Na2Cr2O7 and indi-
cates that Cr(VI) is essentially the only active muta-
gen in this bioassay. For the MIG/SS fume one can
conclude that as far as TA 100 is concerned, Cr(VI)
as contained therein has the same mutagenic po-
tency as does Cr(VI) from nonfume sources. The ob
servation of the significant reduction in the specific
activity of Cr(VI) as contained in MMA/SS fumes, in
agreement with observations of SCE activity in
CHO cells (16,17) has not been explained: compared
to the MIG/SS fume, the chemistry of the MMA/SS
fume matrix is extremely complicated, and the high
Ca2+ and K+ content may well affect the sensitiv-
ity of the bioassay system. In an independent deter-
mination of the response of TA 100 to Cr(VI) (26), it
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FIGURE 3. Variation of the water-soluble and -insoluble
Cr(VI) fractions of MIG/SS and MMA/SS fumes with time
after collection and storage at room temperature. The
MIG/SS data at "zero" time are from analysis of the im-
pinger system: the rest from fumes collected on paper
filters and stored in glass vials.
is observed that although the total-revertant/dose
relationships for Cr(VI) from dichromate, MIG/SS
and MMA/SS fume are quantitatively the same as
reported above, preliminary use of the replica plat-
ing technique indicates that all three systems may
in fact induce the same number of true revertants
per dose Cr(VI): dichromate and MIG/SS fume pro-
duce a relative excess of false revertants even at
low doses.
The high specific mutagenicity shown for "old"
MIG/SS fumes in Figure 2 arises from the fact that
chemical analyses for these matrices were per-
formed at a considerable time after the bioassay. It
is found that the Cr(VI) content of MIG/SS matrix is
not stable, but decays, rapidly at first, and then
slowly over long periods of time. Late chemical anal-
ysis systematically yielded a Cr(VI) content which
was lower than that actually present at the time of
the bioassay, hence the apparent increased activity.
Number of Beads
FIGURE 4. Relative number of revertants, fraction of survi-
vors, and relative number of revertants per survivor, as a
function of the number of welding beads of MIG/
SS, for the impinger bacteria suspension system. The total
welding time is 3600 sec, during which 4.8 mg of fume
collected in the impinger.
The behavior of Cr(VI) in the various fume matrices
with time is shown in Figure 3. Although MMA/SS
fume is stable, there is a reduction of Cr(VI) to
Cr(III) due to the presence of Fe(II) in the MIG/SS
matrix (27). The Cr(VI) content at short times can be
established only with the help of the impinger sys-
tem. Some preliminary results are listed in Table 1.
It can be seen that up to 25% of the total Cr is in
the form of Cr(VI) shortly after welding. Reduction
in Cr(VI) content can also be followed as the fume
rises in the collection manifold by withdrawing the
aerosol at different points.
Since it is apparent that welding fume contains a
short-lived mutagen, it is of interest to develop the
in vitro bioassay so as to permit a determination of
the mutagenic activity of fresh fumes, at a time
comparable to that of inhalation. It is found that a
growing suspension of TA 100 can be placed in the
(single) impinger system, which then serves as a
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Table 1. Distribution of chromium in welding fumes.
Fumes collected in Impingers, Fumes collected on paper filters,
% of totala % of total
Impinger 1 Impinger 2 Filter Total
Sol. Insol. Total Sol. Insol. Total Sol. Insol. Total Sol. Insol. Total Soluble Insoluble Total
MIG/SSb
Cr(VI) 0.144c 0.018 0.162 0.624C 0.018 0.64 0.084C 0.09 0.17 0.852 0.126 0.97 0.005-0.38 0.01-0.54 0.02-0.5
Cr(O + III) - d 1.4 1.4 -d 2.48 2.48 - d 1.15 1.15 - d 5.03 5.03 - 3.56-13.78 3.56-13.78
Total 0.14c 1.42 1.56 0.62c 2.50 3.12 0.084c 1.24 1.32 0.85 5.13 6.00e 0.005-0.38 3.60-14.3 4.06-14.3
MIG/SSf
Cr(VI) 2.10g - 2.10 - - - 0.21 0.14 0.35 2.31 0.14 2.45
Cr(O + III) 0.76g 4.2 4.96 - _ _ - 3.26 3.26 0.76 7.46 8.22
Total 2.86c 4.2 7.06 - - - 0.21 3.40 3.61 3.07 7.60 10.67
MMA/SSb
Cr(VI) 2.11g - 2.11 1.31 - 1.31 0.15 0.37 0.52 3.57 0.37 3.94 2.2-4.3 0.03-0.42 2.2-4.5
Cr(O+ III) -g 0.044 0.044 - 0.044 0.044 - - - - 0.088 0.088 0 0.2-2.1 0.2-2.1
Total 2.11c 0.044 2.15 1.31 0.044 1.35 0.15 0.37 0.52 3.57 0.46 4.02 2.2-4.3 0.2-2.5 2.4-6.4
aDoubly deionized water; initial pH 7.0, final pH 6.7.
b2.2 L/min; 0.3 mm jet, No. 1 and 2 impinger.
cAAS determination; may contain a significant contribution from suspended Cr (O + III) particles.
dAssumed to be zero.
eMay indicate incomplete recovery.
f6.3 L/min; 0.4 mm jet, No. 1 impinger.
gDPC determination.
useful device for monitoring specific mutagenicity in
fumes, from one second onward after welding (28).
Welding can be performed almost continuously
with the robot: a series of six beads, each of 180 sec
duration, can be run on a single plate, which can be
changed in 2-3 min. Figure 4 shows the results of a
preliminary impinger run using the same MIG/SS
welding wire used in the previous experiments, at a
choice of the welding parameters (short arc, 17 V,
185 A) which gives essentially maximum Cr(VI) pro-
duction (27). Although the number of revertants ob-
tained from each aliquot shows a maximum versus
fume dose, the number of survivors falls continu-
ously during the run to an ultimate level of the or-
der of 10% of the initial count, leading to an approx-
imtely linear dose-revertants/survivor response.
These studies have reinforced the conclusions
that the active mutagen for TA 100 found in weld-
ing fumes is Cr(VI) and that this material, at least in
the MIG/SS fume matrix, behaves identically as
does Cr(VI) from other sources, in this bioassay sys-
tem. In terms of support for the concept of equiva-
lence of risk, there is evidence that, on an equal
dose basis, Cr(VI) in welding fumes has the same
biological effect as does Cr(VI) from other sources,
and there is no reason to assume that the risk in the
welding industry is mitigated, based on the observa-
tions to date.
On the other hand the specific activity of Cr(VI)
from the MMA/SS matrix is reduced by a factor of
2-4, indicating some interference with the bioassay
due to the presence of the other soluble substances
present in the matrix. If the reduced activity could
be shown to be due to a true antisynergistic effect,
then it might be worthwhile to pursue this line of
investigation to effect a simple genotoxic risk reduc-
tion.
The fact that Cr(VI) is found to decay rapidly in
one fume matrix indicates that there is a serious un-
derreporting of the occupational exposure to this
substance under certain conditions [here the pres-
ence of a reducing agent, Fe(II)]. Presumably this is
true of other mutagens, and any attempt to mea-
sure "risk equivalence" by in vitro (or in vivo) tech-
niques must include the possibility of performing an
assay of the actual work place exposures, and not
only of grab samples returned to the laboratory for
analysis at some later time.
Although the Ames assay with S. typhimurium is
most probably not appropriate for most metals (29)
because of its lack of sensitivity to lipid peroxida-
tion and covalent bonding, it has been convenient
for use as a tool to study Cr(VI) and to permit an as-
sessment of the techniques for exposure, collection
and analysis of a system about which a great deal is
known. The observation of "false" Cr(VI) induced re-
vertants in this system does not affect the conclu-
sions of this article but does restrict the validity of
the results to low Cr(VI) doses. The results of other
studies in the program of in vitro determination of
risk equivalence are presented in several con-
current articles (19, 26, 30).
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Determination of elemental content in various fractions of
welding fumes has been made by E. Thomsen, Technological
Institute, Toastrup. Mutagenicity testing was performed in co-
operation with H. Larsen, P. Kiel, and M. Andersen, Royal
Danish College of Pharmacy, Copenhagen. This work has been
partially supported by The Danish National Fund for Techni-
cal-Scientific Research (STVF).
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